No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

A Moderna spokesperson told MassLive the company is preparing to advance its bird flu vaccine (mRNA-1018) into a phase 3 study, “based on the positive preliminary data from the Phase 1/2 study.” ...

Moderna will receive $176 million to develop a pandemic flu vaccine for humans following a concerning outbreak of bird flu in dairy cows across the country, federal officials announced Tuesday.

Moderna says its H5 bird flu vaccine showed promising results in a trial. ... Avian influenza, or bird flu, is a broad term that refers to several types of influenza that normally infect birds.

Pharmaceutical manufacturer Moderna is set to receive $176 million in federal funding to develop a human vaccine against bird flu following outbreaks of the virus in dairy cows across several ...

A Moderna influenza vaccine for avian influenza, or “bird flu,” will head into a pivotal clinical trial with $176 million in funding from the U.S. federal government.. The funding announced by ...

Moderna Nears Bird Flu Vaccine Deal With U.S. As the H5N1 outbreak spreads from birds to cattle, Moderna will get government funding for a large-scale trial of its mRNA vaccine.

The Trump administration has canceled a $766 million contract with Moderna for the development of a human bird flu vaccine, the pharmaceutical company announced Wednesday.. The Biden ...

Moderna said Wednesday that an early-phase trial of its mRNA-based vaccine against H5 bird flu in about 300 healthy adults showed “a rapid, potent and durable immune response.” ...